A Novel Sensitive Immunoassay Targeting the 5-Methylthio- d -Xylofuranose–Lipoarabinomannan Epitope Meets the WHO's Performance Target for Tuberculosis Diagnosis

Author:

Sigal George B.1,Pinter Abraham2,Lowary Todd L.3,Kawasaki Masanori4,Li Andra5,Mathew Anu1,Tsionsky Michael1,Zheng Ruixiang Blake3,Plisova Tatiana1,Shen Ke3,Katsuragi Kiyonori4,Choudhary Alok2,Honnen William J.2,Nahid Payam6,Denkinger Claudia M.7,Broger Tobias7ORCID

Affiliation:

1. Meso Scale Diagnostics, LLC, Rockville, Maryland, USA

2. Public Health Research Institute Center, New Jersey Medical School, Rutgers University, Newark, New Jersey, USA

3. Department of Chemistry, Alberta Glycomics Centre, University of Alberta, Edmonton, AB, Canada

4. Otsuka Pharmaceutical Co., Ltd., Tokyo, Japan

5. Immunoprecise Antibodies Ltd., Victoria, British Columbia, Canada

6. Division of Pulmonary and Critical Care Medicine, University of California, San Francisco, San Francisco, California, USA

7. FIND, Geneva, Switzerland

Abstract

The only currently commercialized point-of-care assay for tuberculosis (TB) that measures lipoarabinomannan (LAM) in urine (Alere LF-LAM) has insufficient sensitivity. We evaluated the potential of 100 novel monoclonal antibody pairs targeting a variety of LAM epitopes on a sensitive electrochemiluminescence platform to improve the diagnostic accuracy.

Funder

Global Health Innovative Technology Fund

UK Department for International Deelopment

Dutch Ministry of Foreign Affairs

HHS | National Institutes of Health

HHS | NIH | National Institute of Allergy and Infectious Diseases

Alberta Glycomics Centre

Bill and Melinda Gates Foundation

Publisher

American Society for Microbiology

Subject

Microbiology (medical)

Reference47 articles.

1. World Health Organization. 2017. Global tuberculosis report 2017. World Health Organization, Geneva, Switzerland.

2. Quality of tuberculosis care in high burden countries: the urgent need to address gaps in the care cascade

3. Tuberculosis

4. Xpert MTB/RIF Ultra for detection of Mycobacterium tuberculosis and rifampicin resistance: a prospective multicentre diagnostic accuracy study

5. Svenson S. September 1997. Method of diagnosing a mycobacterial disease and immunoassay kit.Patent WO1997034149.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3